Van Haute, Lindsey https://orcid.org/0000-0001-7809-1473
Páleníková, Petra https://orcid.org/0000-0002-2465-4370
Tang, Jia Xin
Nash, Pavel A
Simon, Mariella T https://orcid.org/0000-0002-8200-3277
Pyle, Angela
Oláhová, Monika
Powell, Christopher A https://orcid.org/0000-0001-7501-0586
Rebelo-Guiomar, Pedro https://orcid.org/0000-0002-5060-7519
Stover, Alexander
Champion, Michael
Deshpande, Charulata
Baple, Emma L
Stals, Karen L
Ellard, Sian
Anselem, Olivia
Molac, Clémence
Petrilli, Giulia
Loeuillet, Laurence
Grotto, Sarah
Attie-Bitach, Tania
Abdenur, Jose E
Taylor, Robert W https://orcid.org/0000-0002-7768-8873
Minczuk, Michal https://orcid.org/0000-0001-8242-1420
Funding for this research was provided by:
UKRI | Medical Research Council (MC_UU_00015/4)
UKRI | Medical Research Council (MR/S005021/1)
UKRI | Medical Research Council (MR/W019027/1)
UKRI | Medical Research Council (MC_PC_21046)
Newcastle University | Wellcome Trust Centre for Mitochondrial Research (203105/Z/16/Z)
Lily Foundation
Newcastle University | Faculty of Medical Sciences, Newcastle University
Mitochondrial Disease Patient Cohort (G0800674)
Medical Research Council International Centre for Genomic Medicine in Neuromuscular Disease (MR/S005021/1)
NIHR Biomedical Research Centre for Ageing and Age-related disease award to the Newcastle upon Tyne Foundation Hospitals NHS Trust
Pathological Society of Great Britain and Ireland
LifeArc
UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children
Mito Foundation
AFM Téléthon
Champ Foundation
EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (721757)
Article History
Received: 5 April 2024
Revised: 18 October 2024
Accepted: 29 October 2024
First Online: 20 November 2024
Disclosure and competing interests statement
: MM is a founder, shareholder and member of the Scientific Advisory Board of Pretzel Therapeutics, Inc. LVH is director of NextGenSeek Ltd. The remaining authors declare no competing interests.